Published in Leukemia on March 18, 2010
Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics (2010) 1.63
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet (2010) 1.44
Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen (2012) 1.27
Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res (2011) 1.15
Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Epigenetics (2012) 1.11
Increased mitochondrial DNA copy number in occupations associated with low-dose benzene exposure. Environ Health Perspect (2011) 1.02
Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes. Epigenetics (2014) 1.01
Origins of aberrant DNA methylation in acute myeloid leukemia. Leukemia (2013) 1.00
Dissecting DNA hypermethylation in cancer. FEBS Lett (2010) 0.98
Epigenetic responses to drought stress in rice (Oryza sativa L.). Physiol Mol Biol Plants (2013) 0.89
Network analysis of reverse phase protein expression data: characterizing protein signatures in acute myeloid leukemia cytogenetic categories t(8;21) and inv(16). Proteomics (2012) 0.89
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation. Clin Epigenetics (2014) 0.86
Role of epigenetics in chronic myeloid leukemia. Curr Hematol Malig Rep (2013) 0.84
TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells. Prostate (2013) 0.84
Storage conditions and stability of global DNA methylation in placental tissue. Epigenomics (2013) 0.84
The association between first trimester micronutrient intake, MTHFR genotypes, and global DNA methylation in pregnant women. J Matern Fetal Neonatal Med (2011) 0.80
Alterations in DNA methylation corresponding with lung inflammation and as a biomarker for disease development after MWCNT exposure. Nanotoxicology (2015) 0.80
A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies. Haematologica (2012) 0.79
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2'-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza). Pharmaceuticals (Basel) (2012) 0.78
DNMT3A: the DioNysian MonsTer of acute myeloid leukaemia. Ther Adv Hematol (2014) 0.78
Next generation sequencing: advances in characterizing the methylome. Genes (Basel) (2010) 0.78
Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia. BMC Cancer (2015) 0.78
DNA methylation modifies the association between obesity and survival after breast cancer diagnosis. Breast Cancer Res Treat (2016) 0.77
DNA methylation screening and analysis. Methods Mol Biol (2012) 0.77
Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients. Int J Mol Med (2014) 0.76
Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia. Epigenetics (2015) 0.76
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia. JCI Insight (2016) 0.76
Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway. Oncotarget (2016) 0.75
Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia. J Natl Cancer Inst (2015) 0.75
Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia. J Hematol Oncol (2017) 0.75
Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells. Front Oncol (2017) 0.75
p15ink4b Loss of Expression by Promoter Hypermethylation Adds to Leukemogenesis and Confers a Poor Prognosis in Acute Promyelocytic Leukemia Patients. Cancer Res Treat (2016) 0.75
Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML. Int J Genomics (2017) 0.75
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy. Oncotarget (2017) 0.75
Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med (2000) 16.30
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol (1997) 5.18
Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science (2000) 5.10
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation (2000) 3.82
First sexual intercourse: age, coercion, and later regrets reported by a birth cohort. BMJ (1998) 3.14
Signal transduction through prion protein. Science (2000) 3.09
Complete amino acid sequence of the Mu heavy chain of a human IgM immunoglobulin. Science (1973) 2.97
Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. BMJ (2000) 2.87
The human histone deacetylase family. Exp Cell Res (2001) 2.86
Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem (1999) 2.85
Landscape metrics for assessment of landscape destruction and rehabilitation. Environ Manage (2001) 2.65
Oral contraceptives and fatal pulmonary embolism. Lancet (2000) 2.57
Isolation and characterization of multiple human genes homologous to the oncogenes of avian erythroblastosis virus. EMBO J (1983) 2.52
Folding patterns of porin and bacteriorhodopsin. EMBO J (1985) 2.34
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia (2010) 2.30
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia (2010) 2.23
Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol (2000) 2.18
Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci U S A (2001) 2.16
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia (2004) 2.08
Chromosomal localisation of the human homologues to the oncogenes erbA and B. EMBO J (1984) 2.02
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med (2007) 1.97
Epigenetic modulation at birth - altered DNA-methylation in white blood cells after Caesarean section. Acta Paediatr (2009) 1.95
DNMT3A mutations in myeloproliferative neoplasms. Leukemia (2011) 1.95
Sequence relationships of three human satellite DNAs. J Mol Biol (1986) 1.93
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia (2009) 1.92
Waiting for elective surgery: effects on health-related quality of life. Int J Qual Health Care (1999) 1.90
Synthesis and genomic site for an adenovirus type 2 early glycoprotein. J Mol Biol (1980) 1.82
Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene (1998) 1.81
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (1986) 1.81
Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci U S A (2009) 1.79
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia (2005) 1.72
Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost (2010) 1.71
Mammographic screening: results from the 1996 National Breast Health Survey. Med J Aust (1997) 1.71
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML. Leukemia (2012) 1.64
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol (2004) 1.62
IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet (1993) 1.62
Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microb Pathog (1994) 1.61
Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A (1994) 1.59
Importance of the male factor in cancer of the cervix. Lancet (1982) 1.58
Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (1985) 1.58
Epidemiology of pelvic ring injuries. Injury (1996) 1.58
Sample-specific ratio effects in matching to sample. J Exp Anal Behav (1983) 1.58
The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model. Bone Marrow Transplant (2008) 1.56
Epidemiological and experimental studies on a new incident of transmissible mink encephalopathy. J Gen Virol (1991) 1.53
Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol (2007) 1.53
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J Biol Chem (1995) 1.51
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br J Dermatol (2013) 1.50
Occurrence of AIDS in New Zealand: the first seven years. MRC AIDS Epidemiology Group. N Z Med J (1991) 1.48
Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones (2001) 1.47
Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis. Br J Dermatol (2011) 1.47
Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res (1999) 1.47
Pregnancies among New Zealand teenagers: trends, current status and international comparisons. N Z Med J (2000) 1.44
Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) (1986) 1.44
Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance. J Intern Med (2011) 1.44
Revisiting the enzymes stored in the laticifers of Carica papaya in the context of their possible participation in the plant defence mechanism. Cell Mol Life Sci (2001) 1.43
Patterns of disease and HIV testing at sexually transmitted disease clinics. N Z Med J (1997) 1.43
Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. Br J Dermatol (2015) 1.43
Natural killer cells kill tumour cells at a given stage of differentiation. Nature (1981) 1.43
High-frequency ultrasonography but not 930-nm optical coherence tomography reliably evaluates melanoma thickness in vivo: a prospective validation study. Br J Dermatol (2014) 1.42
A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol (2002) 1.42
Novel THAP1 sequence variants in primary dystonia. Neurology (2010) 1.42
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact. Leukemia (2000) 1.39
[Benign desmoplastic fibroblastoma of the lower leg. A rare case]. Unfallchirurg (2004) 1.39
Antibodies to cerebellar soluble lectin CSL in multiple sclerosis. Lancet (1990) 1.39
Oral contraceptives and venous thromboembolism continued. N Z Med J (2000) 1.39
Factors associated with sun protection compliance: results from a nationwide cross-sectional evaluation of 2215 patients from a dermatological consultation. Br J Dermatol (2014) 1.38
The extent of cervical screening in New Zealand women. N Z Med J (1991) 1.38
Incidence of cancer among Pacific Island people in New Zealand. N Z Med J (1993) 1.38
Intraperitoneal microdialysis: Postoperative monitoring of splanchnic ischemia by measurements of the lactate pyruvate ratio. Crit Care Med (2006) 1.37
Analysis of the relationship between viral infection and autoimmune disease. Immunity (2001) 1.32
Petunia Ap2-like genes and their role in flower and seed development. Plant Cell (2001) 1.31
Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab (2001) 1.30
Effects of maternal nutrition on the human fetus. Pediatrics (1973) 1.30
Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species. Neuron (1990) 1.30
Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull World Health Organ (1990) 1.30
Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26
Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship. Proc Natl Acad Sci U S A (2001) 1.25
The small heat shock proteins family: the long forgotten chaperones. Int J Biochem Cell Biol (2012) 1.23
CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals. Br J Dermatol (2009) 1.23
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22
Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol (2000) 1.22
Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci U S A (2000) 1.22
Late presentation of HIV infection among adults in New Zealand: 2005-2010. HIV Med (2011) 1.21
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med (Berl) (1999) 1.21
In situ activation of the type 2 ryanodine receptor in pancreatic beta cells requires cAMP-dependent phosphorylation. Proc Natl Acad Sci U S A (1998) 1.21
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Gestational weight gain in accordance to the IOM/NRC criteria and the risk for childhood overweight: a meta-analysis. Pediatr Obes (2012) 1.19
Unlinked anonymous monitoring of HIV prevalence at sexually transmitted disease clinics. N Z Med J (1993) 1.19
Breast cancer screening adherence: does church attendance matter? Health Educ Behav (1998) 1.18
Quality of life in thalassemia major: reliability and validity of the Persian version of the SF-36 questionnaire. J Postgrad Med (2008) 1.17
The lifetime occurrence of sexually transmitted diseases among a cohort aged 21. N Z Med J (1996) 1.17